These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 27030498)
1. [Expression and clinical significance of ELOVL6 gene in high-grade serous ovarian carcinoma]. Li FJ; Wang HY; Feng XL; Li PP; Shu T; Zhao XH; Li B Zhonghua Fu Chan Ke Za Zhi; 2016 Mar; 51(3):192-7. PubMed ID: 27030498 [TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of HER3 based on protein and mRNA expression in high-grade serous ovarian carcinoma. Unger U; Denkert C; Braicu I; Sehouli J; Dietel M; Loibl S; Darb-Esfahani S Virchows Arch; 2017 Feb; 470(2):143-151. PubMed ID: 27913862 [TBL] [Abstract][Full Text] [Related]
3. [Expression of mesothelin mRNA and protein in ovarian carcinomas]. Bi SN; Dai SZ; Yao Q; Che YC; Wang N Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):288-91. PubMed ID: 18788634 [TBL] [Abstract][Full Text] [Related]
4. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Elloul S; Elstrand MB; Nesland JM; Tropé CG; Kvalheim G; Goldberg I; Reich R; Davidson B Cancer; 2005 Apr; 103(8):1631-43. PubMed ID: 15742334 [TBL] [Abstract][Full Text] [Related]
5. [Human pituitary tumor transforming gene 1 expression in ovarian carcinoma and its clinical significance]. Cheng YX; Feng J; Zhang XY; Fu TY; Yao Y Ai Zheng; 2004 Sep; 23(9):1026-30. PubMed ID: 15363195 [TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of the cancer stem cell-related marker NANOG in ovarian serous carcinoma. Lee M; Nam EJ; Kim SW; Kim S; Kim JH; Kim YT Int J Gynecol Cancer; 2012 Nov; 22(9):1489-96. PubMed ID: 23095773 [TBL] [Abstract][Full Text] [Related]
7. ELF5 in epithelial ovarian carcinoma tissues and biological behavior in ovarian carcinoma cells. Yan H; Qiu L; Xie X; Yang H; Liu Y; Lin X; Huang H Oncol Rep; 2017 Mar; 37(3):1412-1418. PubMed ID: 28184931 [TBL] [Abstract][Full Text] [Related]
8. Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy. Santin AD; Zhan F; Bellone S; Palmieri M; Cane S; Bignotti E; Anfossi S; Gokden M; Dunn D; Roman JJ; O'Brien TJ; Tian E; Cannon MJ; Shaughnessy J; Pecorelli S Int J Cancer; 2004 Oct; 112(1):14-25. PubMed ID: 15305371 [TBL] [Abstract][Full Text] [Related]
9. [Expression of EVEC in ovarian carcinoma and its biological significance]. Wang Q; Li XG; Zhang Y; Cao LQ; Deng ZH; Chen Y Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):676-80. PubMed ID: 21122382 [TBL] [Abstract][Full Text] [Related]
10. HUR mRNA expression in ovarian high-grade serous carcinoma effusions is associated with poor survival. Davidson B; Holth A; Hellesylt E; Hadar R; Katz B; Tropé CG; Reich R Hum Pathol; 2016 Feb; 48():95-101. PubMed ID: 26640230 [TBL] [Abstract][Full Text] [Related]
11. [Overexpression of high mobility group A2 and its correlation with microRNA let-7 family in serous ovarian cancers]. Yang J; Zhang Q; Dong JQ; Chang XH; He XJ Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):749-54. PubMed ID: 23073586 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy. Bellone S; Siegel ER; Cocco E; Cargnelutti M; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD Int J Gynecol Cancer; 2009 Jul; 19(5):860-6. PubMed ID: 19574774 [TBL] [Abstract][Full Text] [Related]
13. Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer. Kusuda T; Shigemasa K; Arihiro K; Fujii T; Nagai N; Ohama K Oncol Rep; 2005 Jun; 13(6):1153-8. PubMed ID: 15870936 [TBL] [Abstract][Full Text] [Related]
14. [Expression and role of glucose-regulated protein 78 in ovarian serous adenocarcinoma]. Fan LM; Su J; Dong H; Wei M; Cui MH Zhonghua Yi Xue Za Zhi; 2013 Mar; 93(9):659-62. PubMed ID: 23751742 [TBL] [Abstract][Full Text] [Related]
15. BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer. Chao A; Tsai CL; Jung SM; Chuang WC; Kao C; Hsu A; Chen SH; Lin CY; Lee YC; Lee YS; Wang TH; Wang HS; Lai CH PLoS One; 2015; 10(7):e0133081. PubMed ID: 26222696 [TBL] [Abstract][Full Text] [Related]
16. Expression and clinical role of chemoresponse-associated genes in ovarian serous carcinoma. Nymoen DA; Hetland Falkenthal TE; Holth A; Ow GS; Ivshina AV; Tropé CG; Kuznetsov VA; Staff AC; Davidson B Gynecol Oncol; 2015 Oct; 139(1):30-9. PubMed ID: 26232338 [TBL] [Abstract][Full Text] [Related]
17. Expression profile of tight junction protein claudin 3 and claudin 4 in ovarian serous adenocarcinoma with prognostic correlation. Choi YL; Kim J; Kwon MJ; Choi JS; Kim TJ; Bae DS; Koh SS; In YH; Park YW; Kim SH; Ahn G; Shin YK Histol Histopathol; 2007 Nov; 22(11):1185-95. PubMed ID: 17647191 [TBL] [Abstract][Full Text] [Related]
18. [Expression and clinical significance of endostatin and vascular endothelial growth factor in ovarian carcinoma]. Shi HR; Song WJ; Chen ZM; Wu QH Ai Zheng; 2005 Sep; 24(9):1127-31. PubMed ID: 16159439 [TBL] [Abstract][Full Text] [Related]
19. Identification of differentially expressed genes using an annealing control primer system in stage III serous ovarian carcinoma. Kim YS; Hwan JD; Bae S; Bae DH; Shick WA BMC Cancer; 2010 Oct; 10():576. PubMed ID: 20969748 [TBL] [Abstract][Full Text] [Related]
20. Clinical and prognostic significance of lost or decreased PDCD5 expression in human epithelial ovarian carcinomas. Zhang X; Wang X; Song X; Wei Z; Zhou C; Zhu F; Wang Q; Ma C; Zhang L Oncol Rep; 2011 Feb; 25(2):353-8. PubMed ID: 21165576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]